![Xu Tian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xu Tian
Directeur/Bestuurslid bij Beijing Shenogen Pharma Group Ltd.
Profiel
Xu Tian is an Independent Director at Beijing Shenogen Pharma Group Ltd.
since 2019.
She graduated from China University of Political Science & Law with a graduate degree in 1994 and from Tarim University with an undergraduate degree in 1982.
Actieve functies van Xu Tian
Bedrijven | Functie | Begin |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 01-10-2019 |
Opleiding van Xu Tian
Tarim University | Undergraduate Degree |
China University of Political Science & Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |